True, however many companies in similar situation have risen up to 50% in the last week with the biotech rally. OCRX is the anomaly, at least in my portfolio of biotechs. Would be great if the officers and directors could start purchasing some stock with their own funds to show some confidence in this company's future.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.